The safety profile of semaglutide 2.4 mg in STEP 5 was consistent with that in other STEP program trials 6,7,9,16,23 , and with the GLP-1 receptor agonist class in general 28
DES MOINES, Iowa, June 9, 2026 (Newswire.com) - Title Reference Notice: "FeelGood GLP-1" is the consumer-facing product identifier published by FeelGood Health at feelgoodmeds.com
It was initially discovered that GLP- 1 activates adenylate cyclase in tissue from the central nervous system (CNS) [53]
(2020) 13(1):dmm042655 doi: 10.1242/dmm.042655
This often results in a cloudy or milky appearance
NAION is an eye condition caused by decreased blood supply to the optic nerve